Can a Sweat Patch Detect Cocaethylene Alongside Cocaine? What 21 GC–MS Patch Results Actually Show

What was the primary forensic question?

The investigators asked whether they could identify two chemically specific analytes—unchanged cocaine and cocaethylene—in material retained by a non-occlusive sweat patch. A patch collects secretions over an interval, and a laboratory must then separate the compounds from the absorbent pad and its extract. These are separate questions: whether the patch retained an analyte, whether the preparation released it, and whether the analytical instrument identified it at its detection criteria.

At the time, sweat testing was attractive because application was relatively unobtrusive and could span multiple days. The attraction has a tradeoff. A patch has an exposure interval, rather than a sharply timed blood draw; its collected mass reflects several interacting variables. The study’s actual endpoint was feasibility and laboratory performance of an analytical method, not the predictive accuracy of a clinical diagnosis or a forensic chronology.

How many people and patch specimens were actually studied?

The field component enrolled 11 adult volunteers receiving inpatient treatment for cocaine use. Investigators collected 21 sweat-patch specimens from those individuals. The patches were worn for approximately three to seven days. The correct biological denominator for recruited people is 11; the correct analytical specimen denominator for reported patch results is 21. Patches are repeated or otherwise grouped observations from those people, not 21 independently recruited participants.

The paper does not give a complete person-by-person table linking each patch to a unique participant, a supervised drug dose, blood toxicology, and a corresponding event time. Therefore, nine cocaine-positive patches do not establish that nine different people tested positive. Nor can one divide the number of positive patches by 11 to obtain a valid individual prevalence. The observed patch count answers a different question from individual exposure frequency.

The original study also used deliberately fortified negative sweat patches for analytical validation. Those laboratory replicates test performance under defined conditions. They are not additional people, additional natural exposure episodes, or prospective independent confirmatory cases.

Why look for cocaethylene in a cocaine specimen?

Cocaethylene is a distinct cocaine-related compound associated with cocaine and ethanol being present during metabolism. Detecting it can provide information that differs from detecting unchanged cocaine alone. Its molecular identity is important: cocaethylene is not benzoylecgonine, not ethanol, and not simply a larger cocaine peak. An analytical method must include its own reference material and identification criteria to distinguish it from cocaine and potential interferences.

That chemical relationship does not convert a sweat-patch result into proof of the volume of alcohol consumed, a measured blood-alcohol concentration, or the date of the co-exposure. The paper did not administer controlled cocaine or ethanol doses, did not collect paired timed blood specimens, and did not validate a model that turns patch analyte mass into an individual cocaine–alcohol timeline. A positive cocaethylene result is evidence about the compound identified in the tested patch. Any statement about a person’s specific circumstances would require additional independently obtained evidence.

How did the team collect and prepare sweat?

The researchers used PharmChek non-occlusive patches consisting of an absorbent cellulose pad under an adhesive backing. They cleaned a suitable skin site with a 70% isopropanol swab before application. Once a patch was recovered, the cellulose material was placed in 2.5 mL of 0.2 molar sodium acetate buffer at pH 5.0 for 15 minutes. The preparation was centrifuged for 10 minutes at approximately 300 times gravitational force to obtain an extract.

Deuterium-labeled cocaine and cocaethylene internal standards were added to that extract. The team immersed a 100-µm polydimethylsiloxane SPME fiber in the fluid for 20 minutes with stirring. The fiber was then placed into the heated chromatograph injector to thermally desorb the captured compounds. This approach avoided a conventional solvent-intensive solid-phase extraction step, but it still depended on efficient transfer from pad to buffer and from buffer to analytical fiber.

That dependence is material to interpretation. A low yield from the pad and a highly precise mass spectrometer can coexist. Good chromatographic identification does not itself resolve incomplete release from the original collection medium, collection variability, environmental contamination, or the unknown total volume of sweat.

How were cocaine and cocaethylene identified?

The separation system combined gas chromatography with electron-impact mass spectrometry operated in selected-ion-monitoring mode. The source identifies monitoring ions for cocaine at mass-to-charge values 182, 272, and 303, and cocaethylene at 196, 272, and 317. Isotopically labeled analogues supported the analyses. The paper also describes retention-time and relative-ion-ratio acceptance criteria for the detection-limit work.

These details matter because a forensic report should not rely on the generic phrase “drug test positive” where the underlying method targeted two defined chemical structures. Mass-spectrometric identification under specified criteria is different from a broad immunoassay screen. It is also different from proving that all conceivable contaminants have been excluded in a later, unrelated case. The instrument configuration and quality-control results must be reviewed for the actual run and the actual specimens.

For general context, the site’s guide to confirmatory drug testing explains why compound identity, method scope, and specimen-specific validation must remain connected.

What were the measured detection limit, recovery, and precision?

The authors reported an empirical limit of detection of 5 ng/mL in the 2.5-mL patch extract, equivalent to 12.5 ng of analyte per patch, for both cocaine and cocaethylene. This is a limit of detection, not a validation of precise quantification of a person’s sweat concentration. The source also reports repeatability and between-day precision using fortified control materials. Those values quantify repeatability of the laboratory process under the tested conditions, not the biological variability of an unobserved person’s sweat production.

These are the primary publication’s tabulated figures, not independently revalidated values. Importantly, recovery was markedly different between the two fortification levels, even where replicate precision was reasonably narrow. Accuracy or recovery and precision therefore should not be collapsed into one generic assurance that a patch result is “reliable.” The source includes no significance test establishing equivalence of recovery across fortification levels; the numerical difference must be described, not promoted to an unreported p-value.

What did the 21 authentic patches show?

Of the 21 patch specimens, nine produced reported positive results for cocaine with the developed procedure. Only one cocaine-positive patch also yielded reported cocaethylene. The authors included chromatographic examples of a fortified specimen, a blank, and an authentic user specimen. These analytical examples demonstrate that the selected ions can appear in different configurations under the instrument method. They do not provide a full validation of individual sensitivity and specificity for timing of combined drug ingestion.

These counts do not permit an estimate of the method’s clinical sensitivity, false-positive rate in a population without exposure, or degree of concordance with blood or urine. Controlled reference exposure and independent comparator testing would be needed for those questions. The real-specimen results are best understood as a small demonstration of analytical applicability to patches from a selected inpatient cohort.

Why does a lower limit of detection not establish an accurate dose?

The analytical limit answers approximately how little target material the procedure could identify under its acceptance criteria. A dose estimate would require a relationship between known administered amount, absorption, pharmacokinetics, transfer into sweat, collection interval, sweating rate, recovery, and instrument response. The Follador experiment did not establish that chain for individual cases.

The authors expressly discuss how the unknown volume of sweat collected by a patch and variation in sweating, body site, and wear time prevent straightforward concentration interpretation. A mass in ng/patch has different units and biological meaning from ng/mL in venous whole blood. Likewise, 5 ng/mL of the laboratory’s acetate extract is not 5 ng/mL of a person’s collected natural sweat. The former is the concentration in a defined 2.5-mL elution volume; the latter denominator was never measured.

The paper also discusses an older proposed sweat-patch reporting reference near 25 ng/patch. That historical reference must not be presented as today’s universal statutory or program-specific cutoff. A detection limit, laboratory decision threshold, legal per se threshold, and impairment threshold are four distinct concepts, each requiring its own authority and validation.

Why does recovery change between the fortified levels?

Recovery means the amount carried through the specimen-preparation procedure relative to an analytical reference. At the lower fortification, the reported recoveries were near 100%; at the higher fortification, they were substantially lower. The design compared patches fortified before preparation against a reference added directly to buffer. Such comparisons are useful for evaluating losses associated with the pad and preparation, but they do not establish a physical mechanism for every difference observed.

The practical consequence is narrower than a simple quality label. If the assay is intended to make quantitative claims, the validation must address concentration-dependent recovery over the proposed measurement range. If it is intended principally for identification near a defined threshold, the performance must be sufficient for that intended purpose. The study expressly characterizes the resulting approach as semi-quantitative. It does not establish a validated subject-specific mass balance for sweat accumulation.

What did the storage experiment establish?

The investigators fortified patches and examined storage under selected conditions. The publication reports less than 2% cocaine loss after seven days at room temperature and after 14 days at 4 °C. For cocaethylene, approximately 17% loss was observed by the fifth day at room temperature and by day 14 at 4 °C. Those observations suggest that the two targets need not share identical stability profiles in the tested patch system.

These were limited laboratory checks, not a universal stability guarantee for every temperature excursion, adhesive material, wet specimen, shipping delay, freeze–thaw cycle, or evidence-storage environment. When a real patch is collected days after application, its handling history also influences interpretation. A laboratory reviewer should ask when the patch was removed, whether it remained sealed, the time to extraction, and what control results support stability for that handling path.

What can a cocaethylene-positive patch suggest—and what can it not prove?

A properly identified cocaethylene finding can support the presence of that specific compound on or within the collected patch. Because cocaethylene is associated with cocaine and ethanol co-exposure, it may be consistent with an episode in which both substances were in the body. But consistency is not the same as a uniquely demonstrated mechanism in a given person. Questions about environmental transfer, specimen provenance, laboratory artifacts, storage, and the rest of the case record remain separate.

The study did not compare cocaethylene-positive patches to contemporaneous quantitative blood ethanol testing, did not determine the timing of combined ingestion, and did not report incident-specific impairment. A conclusion that a subject drank alcohol at an exact time or had a particular blood alcohol concentration would require evidence absent from this protocol. The fact that one of 21 authentic patches showed cocaethylene is particularly unsuitable as the basis for broad estimates of sensitivity for concurrent cocaine-and-alcohol use.

How should analysts address contamination and sample provenance?

A skin-applied patch is not immune to contamination merely because a manufacturer describes it as resistant to tampering. Surface contact, application quality, skin cleansing, patch integrity, recovery method, and sample handling are factual details that must be independently established. Follador and colleagues cleaned the skin before applying the patches, but this small study was not a controlled challenge of every conceivable contamination mode. It does not supply a general false-positive percentage attributable to environmental cocaine contamination.

An appropriately focused review should identify the collector, placement and removal dates, patch location, wear duration, visible integrity, seal and custody records, laboratory accession, extraction control, isotope-standard results, chromatographic identity criteria, blanks, calibrators, and confirmation/reporting policy. If the report consists only of a positive/negative label without these documents, the label may conceal crucial uncertainties about what actually happened to the specimen.

Why a sweat patch is not a blood or oral-fluid result

Biological matrices operate on different sampling principles. Venous whole blood is a specimen of circulating blood at a collection time; plasma and serum separate different fractions from blood. Urine collects excreted analytes and metabolites over an evolving interval. Oral fluid reflects different partitioning and collection factors. Hair adds growth, cosmetic-treatment, and external-exposure considerations. A sweat patch accumulates material on a collection pad over the time it remains attached.

There is no validated conversion in this 2004 paper from ng/patch to a legal venous whole-blood cocaine or cocaethylene result, and there are no participant-matched whole-blood samples with which to derive one. The site’s published biological-matrices guide provides a broader specimen-comparison framework. A case opinion should identify which matrix was actually analyzed instead of moving a number across specimens by analogy.

Were any group differences statistically significant or nonsignificant?

This is principally an analytical method-development and small real-specimen demonstration, not a randomized comparison of drug effects. The numerical recovery, precision, detection-limit, stability, and field positivity figures are reported descriptively. The investigators did not publish p-values proving a statistically significant difference in drug intake, impairment, cocaethylene detectability across populations, or recovery equivalence between fortification levels. It would be erroneous to invent such tests.

Likewise, the absence of reported cocaethylene in 20 of the 21 patches is a set of non-detections under a defined procedure, not a statistically demonstrated absence of drinking, absence of cocaine use, or nonsignificant cognitive outcome. The analytical limit and sampling interval matter. Method-validation percentages have measurement uncertainty and replicate limits, but the paper does not provide every population-level uncertainty parameter needed for an individualized probability statement.

What should a forensic reviewer ask before relying on the result?

Begin by requesting the original collection and laboratory records rather than substituting the 2004 study for validation of a later laboratory’s own procedure. Confirm the device, material, wearer, dates, removal conditions, evidence seal, and storage temperatures. Identify exactly which drugs were sought and whether the lab measured a mass on the pad, a concentration in elution buffer, or merely a categorical positive. Examine how the calibration and reporting limits were established for that laboratory’s version of the method.

Then inspect the chromatograms and ion ratios for both cocaine and cocaethylene; verify internal-standard performance, blanks, carryover, calibration acceptance, replicate or control data, and sign-off procedures. Finally, separate identification from interpretation. An identified compound can be scientifically informative even when the evidence is insufficient for dose, ingestion time, on-road performance, or causation. The correct conclusion may be deliberately narrow, because narrower conclusions are sometimes the ones the data genuinely support.

Seven questions frequently raised about cocaine and cocaethylene sweat patches

1. Can the patch prove that a person used cocaine on a particular date?

No. A multi-day patch gathers material during a wear interval. Even a confirmed cocaine finding cannot, from this study alone, be assigned to a specific minute or hour. The application/removal record and any independent contemporaneous evidence should be examined, but the method was not validated as a precise event-time clock.

2. Does finding cocaethylene always prove exactly how much alcohol was consumed?

No. Cocaethylene is chemically distinct and associated with cocaine–ethanol co-exposure, but the original protocol did not control or quantify alcohol administration in the 11 participants. It measured neither ethanol dose nor contemporaneous blood ethanol, and it did not validate a conversion to alcohol units or impairment.

3. Were there 21 cocaine users or 21 different positive people?

Neither conclusion follows. Eleven people contributed 21 patch specimens; nine patches were reported positive for cocaine. Repeated or multiple patches from a participant do not make that person an independent additional research subject. The original presentation does not support counting nine separate cocaine-positive individuals.

4. Is the detection limit the same as the legal positive cutoff?

No. The 12.5-ng/patch figure is the reported empirical detection limit. A reporting cutoff is a separate laboratory or program rule, while a legal threshold may be defined by a jurisdiction and a different matrix. This study does not establish a generally applicable legal impairment cutoff or authorize substitution of the extract concentration for blood concentration.

5. Does GC–MS make contamination or chain-of-custody issues irrelevant?

No. GC–MS can support specific chemical identification within its method scope, but it cannot itself prove who wore the patch, whether the device remained intact, how the patch was handled, or whether a detected compound reached the pad through the asserted route. Those matters require specimen and case evidence.

6. Why do cocaine and cocaethylene have different recovery and stability behavior?

The study actually reported separate target-specific performance. At 125 ng per fortified patch, cocaine recovery was 58% and cocaethylene recovery 50%. Under the evaluated conditions, cocaethylene showed about 17% storage loss whereas cocaine loss was below 2%. The paper did not establish the exact cause of every difference; the findings instead show why analytes need their own validation.

7. Could these sweat-patch findings establish that a driver was impaired?

No. Participants performed no driving task, no validated psychomotor examination, and no dose-controlled impairment assessment. The actual biological matrix was a patch extract, not legal whole blood collected near an incident. An impairment opinion would require separate validated pharmacological, behavioral, temporal, and case-specific evidence.